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Physiological Sciences, School of Life Science, Graduate University for Advanced Studies, Aichi, JapanABSTRACT The transient receptor potential A1 channel (TRPA1) is activated by various compounds, including isothiocya-
nates, menthol, and cinnamaldehyde. The sensitivities of the rodent and human isoforms of TRPA1 to menthol and the
cysteine-attacking compound CMP1 differ, and the molecular determinants for these differences have been identified in the
5th transmembrane region (TM5) for menthol and TM6 for CMP1. We recently reported that caffeine activates mouse
TRPA1 (mTRPA1) but suppresses human TRPA1 (hTRPA1). Here we aimed to identify the molecular determinant that is
responsible for species-specific differences in the response to caffeine by analyzing the functional properties of various chimeras
expressed in Xenopus oocytes. We initially found that the region between amino acids 231 and 287, in the distal N-terminal cyto-
plasmic region of mTRPA1, is critical. In a mutagenesis study of this region, we subsequently observed that introduction of
a Met268Pro point mutation into mTRPA1 changed the effect of caffeine from activation to suppression. Because the region
including Met-268 is different from other reported ligand-binding sites and from the EF-hand motif, these results suggest that
the caffeine response is mediated by a unique mechanism, and confirm the importance of the distal N-terminal region for regu-
lation of TRPA1 channel activity.INTRODUCTIONTransient receptor potential (TRP) channels are widely ex-
pressed in species ranging from nematodes to mammals.
The superfamily consists of various members belonging to
the TRPC, TRPV, TRPM, TRPN, TRPA, TRPP, and
TRPML subfamilies (1–4). Among these, TRPA1, which
was initially named ANKTM1 and contains an ankyrin
repeat domain in its N-terminal region, is expressed in
subsets of the dorsal root ganglion (DRG) neurons that
mediate nociceptive signaling (5,6). As such, TRPA1 is acti-
vated by various pungent compounds and environmental
irritants, many of which are plant-derived products such as
allyl isothiocyanate (AITC) found in wasabi, horseradish,
and mustard oils; allicin found in garlic; cinnamaldehyde
from cinnamon oil; menthol from peppermint oil; D9-tetra-
hydrocannabinol from marijuana; and sanshool from
Sichuan peppers (6–11). Other chemical activators of
TRPA1 include formaldehyde, 4-hydroxynonenal (an
endogenous aldehyde), methyl p-hydroxybenzoate (an anti-
bacterial compound in cosmetics), H2O2, and Zn
2þ (5,12–
17). Activation of TRPA1 by these reactive substances is
thought to be mediated by their covalent modification of
amino acid residues such as Cys (12,18). TRPA1 is also acti-
vated by nonreactive substances such as icilin (a synthetic
TRPM8 agonist), intracellular Ca2þ, alkaline intracellular
pH, and nicotine (5,19–22). Activation of TRPA1 by
noxious cold temperatures has also been reported (5,7),Submitted March 5, 2010, and accepted for publication October 13, 2010.
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0006-3495/10/12/3609/10 $2.00but it remains controversial whether this activation is a direct
effect of the cold (8,19,23). Karashima et al. (24) recently
reported evidence that mouse TRPA1 acts as a cold sensor
both in vitro and in vivo.
In a previous study (25) we observed, using Ca2þi
imaging and electrophysiological recording, that mouse
TRPA1 (mTRPA1) in heterologous expression systems
and in DRG neurons could be activated by caffeine at
millimolar concentrations. We confirmed that the current
was carried by mTRPA1 by noting that the response to
caffeine was absent in DRG neurons from TRPA1 gene
knock-out (KO) mice. Furthermore, we found that wild-
type (WT), but not KO mice, were averse to drinking
caffeine-containing water in a two-bottle test. Of note,
however, we observed that human TRPA1 (hTRPA1) was
not activated by caffeine, and instead was suppressed, espe-
cially after activation by AITC.
There are other examples of species-specific qualitative
differences in TRPA1 responses (26–29). For example, the
trichloro(sulfanyl)ethyl benzamides AMG5445 and
AMG9090 act as partial agonists of rat TRPA1 (rTRPA1),
but act as antagonists to hTRPA1 (26). The thioaminal-con-
taining compound CMP1, which covalently modifies Cys
residues, activates rTRPA1 but blocks hTRPA1, and amino
acid residues in the 6th transmembrane (TM6) region are
critical for that difference (27). Menthol activates mTRPA1
at low concentrations and blocks it at high concentrations,
but only activates hTRPA1, and amino acid residues in
TM5 are involved in that difference (28).
Caffeine is not a reactive chemical reagent, and it is
unknown which region of TRPA1 is critical for activation
by caffeine. In this study, we aimed to identify the moleculardoi: 10.1016/j.bpj.2010.10.014
3610 Nagatomo et al.determinant that is responsible for the species-specific
difference between mTRPA1 and hTRPA1. To that end,
we carried out chimera studies and observed that it is not
a TM region but the N-terminal cytoplasmic region that is
responsible. We then used point mutagenesis to identify
the critical amino acid residue.MATERIALS AND METHODS
Molecular biology
mTRPA1 cDNA was isolated by polymerase chain reaction (PCR), and the
DNA sequence was identical to that deposited in the database (25). The
hTRPA1 cDNAwas provided by Dr. Patapoutian (Scripps Research Institute,
La Jolla, CA). All chimeras were constructed using a two-step PCR method
with PCR primers at the N- and C-ends and at the junction region. The ampli-
fication was done using KOD plus polymerase (TOYOBO, Tokyo, Japan) or
ExTaq DNA polymerase (TAKARA, Tokyo, Japan) according to the manu-
facturer’s instructions. All point mutations were introduced into mTRPA1 or
hTRPA1 cDNA using a QuikChange kit (Stratagene, La Jolla, CA). All
constructs were confirmed by DNA sequencing. cRNA for oocyte injection
was transcribed in vitro using a mMESSAGE mMACHINE transcription
kit (Ambion, Austin, TX).20 mM Caffeine
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Chemicals
For the experiments, we purchased caffeine from Kanto Chemical (Tokyo,
Japan), AITC from Tokyo Kasei (Tokyo, Japan), camphor from Sigma
(St. Louis, MO), and sucrose from Wako Chemicals (Tokyo, Japan). Stock
solutions were made up in recording solution (caffeine) or in DMSO
(AITC, camphor) and stored at 20C. They were diluted in the recording
solution just before use.20 mM Caffeine
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FIGURE 1 Responses to caffeine by mTRPA1 and hTRPA1 expressed in
Xenopus oocytes. (A and C) Representative current traces recorded from
Xenopus oocytes expressing mTRPA1 (A) or hTRPA1 (C) under a two-elec-
trode voltage clamp. In each trace, a 1.5-s ramp pulse from 100
to þ100 mV was applied twice from a holding potential of 20 mV.
Each data set consisted of recordings made without caffeine (first run,
gray) and then with caffeine (second run, black). Caffeine was present
during the time indicated by the bar. (B and D) The ratios of the current
amplitudes recorded at þ80 mV from oocytes expressing mTRPA1 (B) or
hTRPA1 (D) before and after caffeine application plotted against caffeine
concentration. Open circles show data from each oocyte, and the solid dia-
monds and bars indicate means 5 SE. The n-values for each point range
from 2 to 6. The n-value for 0 mM caffeine is the sum of all the other points,
since data before the application of caffeine were recorded as a negative
control in all experiments.Electrophysiology
Xenopus oocytes were surgically isolated from frogs anesthetized in water
containing 0.15% tricaine. After the final collection, the frogs were
humanely killed. Isolated oocytes were treated with collagenase (2 mg/mL,
type I; Sigma, St. Louis, MO) for 5 h, after which oocytes at stage V were
injected with ~50 nL of cRNA solution and incubated at 17C in frog
Ringer solution. Experiments with Xenopus conformed to institutional
guidelines and were approved by the Animal Experiment Committee of
the National Institute for Physiological Sciences.
Membrane currents were recorded from oocytes 1–3 days after cRNA
injection under a two-electrode voltage clamp using an OC725C ampli-
fier (Warner Instruments, Hamden, CT) and pCLAMP8 software (Axon
Instruments, Union City, CA). The microelectrodes used were drawn
from borosilicate glass capillaries (World Precision Instruments, Sarasota,
FL) to a resistance of 0.2–0.5 MU when filled with 3 M KCl (pH 7.2).
The bath solution contained 96 mM NaCl, 2 mM KCl, 3 mM MgCl2, and
5 mM HEPES (pH 7.4), with no added Ca2þ. Oocytes were held
at 20 mV, and the membrane current was continuously recorded with
repeated application of 200-ms ramp pulses from 100 to þ100 mV
every 5 s. All experiments were carried out at room temperature
(23 5 2C). To achieve rapid application of agonists, a one-fifth bath
volume of 5 concentrated solution was pipetted into the bath. We deter-
mined the exchange rate of solutions in the bath of our system by moni-
toring the change in the Kir3.1/3.2 inward rectifier Kþ channel current
upon a Kþ concentration jump, and the time constant of solution
exchange was shown to range from 299 to 533 ms. This speed is suffi-
cient for the analysis of both caffeine effects (see Fig. S5 in the Support-
ing Material).Biophysical Journal 99(11) 3609–3618Statistical analyses
The data are shown as the means5 SE. Differences between means were
analyzed using Student’s unpaired t-test. Values of p < 0.01 were consid-
ered significant.RESULTS
Activation of mTRPA1 and suppression
of hTRPA1 by caffeine
We examined the effects of caffeine on mTRPA1 and
hTRPA1 expressed in Xenopus oocytes by recording the
changes in membrane currents under a two-electrode
voltage clamp with repeated ramp pulses. mTRPA1 was
activated by caffeine, and the EC50-value was ~5 mM
(Fig. 1, A and B). By contrast, hTRPA1 activity was sup-
pressed by caffeine in approximately the same concentra-
tion range (Fig. 1, C and D). An accurate estimation of
EC50 or IC50 was not practically possible, because the
caffeine concentration required to achieve a peak response
was too high.
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FIGURE 2 Schematic drawings of the mTRPA1-hTRPA1 chimeras. The
components of mTRPA1 and hTRPA1 are shown in dark and white, respec-
tively. The positions of the six TM regions are shown in light gray. In the
labels on the left, Mo and Hu stand for mouse and human. Mo705Hu, for
example, indicates that the N-terminal 705 residues are from mTRPA1
and the rest are from hTRPA1. Mo-Hu-Mo and Hu-Mo-Hu are chimeras
in which only the critical region (231–287 in mTRPA1) was swapped.
Determinant of TRPA1 Caffeine Response 3611It is well known that caffeine induces Ca2þ release from
intracellular Ca2þ stores, which raises the possibility that
part of the current elicited by caffeine is not mediated by
the TRPA1 channel. To determine how much of the
caffeine-induced current was carried by TRPA1, we applied
2 mM camphor, a TRPA1 channel blocker, which almost
completely blocked the current (Fig. S1). The percentage
of block of the caffeine-induced current was 95.2 5 2.8%
(n ¼ 4). Moreover, no clear responses were observed in
oocytes not injected with cRNA (see Fig. 8 C) or in untrans-
fected HEK293 cells (25). Thus, the response to caffeine
was confirmed to be mediated almost entirely by the ex-
pressed mTRPA1 channel.
Zhang et al. (30) reported that rTRPA1 responds to hyper-
osmolarity. This raises the possibility that mTRPA1
responds not to the caffeine itself, but to the increase in
osmolarity associated with caffeine application. We there-
fore examined the response to 20 mM sucrose and found
that neither mTRPA1 nor hTRPA1 responded to the increase
in osmolarity, though they clearly responded to positive
control stimuli (Fig. S2 and Table S1 A). Nonetheless, in
subsequent experiments we recorded the responses to
5 mM (10 mM in Fig. 7) caffeine to minimize the potential
effect of hyperosmolarity.mTRPA1
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FIGURE 3 Current recordings of mTRPA1, hTRPA1, Mo705Hu,
Hu703Mo, Mo375Hu, and Hu374Mo. Under a two-electrode voltage
clamp, 200-ms ramp pulses from 100 to þ100 mV were applied every
5 s from a holding potential of 20 mV. Recordings are from oocytes ex-
pressing mTRPA1 WT (A), hTRPA1WT (B), Mo705Hu (C), Hu703Mo
(D), Mo375Hu (E), or Hu374Mo (F). The presence of 5 mM caffeine or
100 mM AITC is indicated by the bars. Panels A–D and panels E and
F are from different batches of oocytes.Use of chimeras to identify the TRPA1 region
critical for the caffeine response
The species-specific difference in the response of TRPA1 to
CMP1 and menthol reportedly reflects the fact that they act
on amino acids in TM6 and TM5, respectively (27,28). On
the other hand, amino acid residues in the N-terminal region
are known to be critical for the binding of agonists such as
AITC (Cys-415, -422, and -622 of mTRPA1) (12) and Ca2þ
(Asp-468 and Asp-479 of hTRPA1 (19), and Leu-474 of
hTRPA1 (20)). To identify the critical region for the
response to caffeine, we designed the set of chimeric
constructs summarized in Fig. 2. In Mo705Hu, the entire
N-terminal cytoplasmic region up to amino acid 705 is
from mTRPA1, and the remainder of the molecule is from
hTRPA1. Hu703Mo has the opposite configuration. Repre-
sentative recordings from oocytes expressing Mo705Hu
and Hu703Mo of the response to caffeine alone and after
activation by AITC are shown in Fig. 3, C and D. It is
obvious that the Mo705Hu phenotype (Fig. 3 C) is similar
to that of mTRPA1 (Fig. 3 A), and that Hu703Mo
(Fig. 3 D) is similar to hTRPA1 (Fig. 3 B), which means
it is not the TM region but the N-terminal cytoplasmic
region that is critical for the difference in the responses to
caffeine. We also analyzed the Mo375Hu and Hu374Mo
chimeras. Mo375Hu was activated by caffeine as well as
by AITC (Fig. 3 E), whereas Hu374Mo was slightly
activated by AITC but was inhibited by caffeine
(Fig. 3 F). This means that the first half of the N-terminal
region is critical for the activation of mTRPA1 by caffeine.It is noteworthy that the critical site for the caffeine response
differs from those for AITC and Ca2þ, and that it is situated
in a more distal part of the N-terminal region. The cumula-
tive data from the experiments represented in Fig. 3 are
summarized in Fig. 4 and Table 1. Here the changes in theBiophysical Journal 99(11) 3609–3618
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FIGURE 4 Analysis of the cumulative data from the experiments in
Fig. 3. The current amplitude at þ100 mV was changed by application of
5 mM caffeine (A, C, D, and F) or by 100 mM AITC (B and E). (A, B,
D, and E) Differences in current amplitudes before caffeine application
and after the 10th pulse after application are shown. (C and F) Caffeine
was applied after the application and subsequent washout of AITC. Differ-
ences between current amplitudes before caffeine application and the
amplitude of the first pulse after application are shown. Panels A–C and
D–F are from different batches of oocytes. Plots depict means 5 SE.
The data and n-values are shown in Table 1.
3612 Nagatomo et al.current amplitude evoked by 5 mM caffeine alone (Fig. 4, A
and D), 100 mM AITC alone (Fig. 4, B and E), and 5 mM
caffeine after activation by AITC (Fig. 4, C and F) are
shown. Note that the data in Fig. 4, A–C, and Fig. 4, D–F,
were obtained from different sets of experiments.TABLE 1 Mean5 SE values of the current amplitudes at þ100 mV
Fig. 4, A–C mTRPA1 WT Mo705Hu
5 mM caffeine 2.125 0.71 2.885 0.80
100 mM AITC 3.985 2.25 4.225 1.45
Caffeine after AITC 7.155 1.21 8.255 2.09
n-value 4 6
Fig. 4, D–F mTRPA1 WT Mo375Hu
5 mM caffeine 3.115 0.34 1.825 0.27
100 mM AITC 4.365 0.39 7.545 1.13
Caffeine after AITC 5.315 0.35 2.675 0.53
n-value 5 7
Fig. 6, A–C mTRPA1 WT Mo327Hu
5 mM caffeine 4.855 0.97 0.575 0.12
100 mM AITC 9.645 2.76 2.735 0.80
Caffeine after AITC 8.725 1.75 2.135 0.42
n-value 4 7
Fig. 6, D–F mTRPA1 WT Mo254Hu
5 mM caffeine 2.135 0.39 1.255 0.11
100 mM AITC 1.565 0.37 15.555 0.84
Caffeine after AITC 5.545 0.79 1.235 0.82
n-value 4 6
Fig. 7, C–E mTPA1 WT Mo-Hu-Mo
10 mM caffeine 1.765 0.48 0.805 0.21
100 mM AITC 3.705 1.34 14.725 3.36
Caffeine after AITC 4.095 0.91 4.085 1.26
n-value 14 10
Biophysical Journal 99(11) 3609–3618Further definition of the critical region for the
caffeine response
To more narrowly define the region that is critical for the
difference in the responses of mTRPA1 and hTRPA1 to
caffeine, we constructed additional chimeras (Fig. 2).
Because the suppressive effect of caffeine was not very clear
in Hu374Mo-expressing oocytes (Figs. 3 F and 4, D and F),
and even the activating effect of AITC was very small (Figs.
3 F and 4 E), we considered it likely that there was a problem
in the functionality or expression of Hu374Mo, and decided
to thereafter concentrate only on the Mo-Hu chimeras
shown in Fig. 2.
Both Mo327Hu and Mo287Hu (Fig. 5, A and B) were
activated upon application of caffeine, suggesting that the
critical region for activation of mTRPA1 is situated in the
distal 287 amino acids of the N-terminal region. In oocytes
expressing Mo230Hu (Fig. 5 C), caffeine clearly suppressed
the current, and the phenotype was similar to that of WT
hTRPA1 (Fig. 3 B), indicating that the critical region for
activation of mTRPA1 is not present in the distal 230 amino
acids. The phenotype of Mo254Hu (Fig. 5 D) was clearly
different from either WT mTRPA1 (Fig. 3 A) or
Mo230Hu (Fig. 5 C). Upon application of caffeine, the
current amplitude increased slightly but then immediately
started to decline, reflecting the presence of activation as
well as activation-coupled desensitization, inactivation, or
block. This was more prominently observed when caffeine
was applied after activation by AITC (Fig. 5 D). As
expected, the phenotypes of Mo201Hu (Fig. 5 E) and(mA) in the category plots
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FIGURE 5 Current recordings for Mo327Hu,
Mo287Hu, Mo230Hu, Mo254Hu, Mo201Hu, and
Mo121Hu. Details of the experiments are the
same as in Fig. 3. Panels A–C and D–F are from
different batches of oocytes.
Determinant of TRPA1 Caffeine Response 3613Mo121Hu (Fig. 5 F) were also similar to that of WT
hTRPA1 (Fig. 3 B). The cumulative results of the two sets
of experiments shown in Fig. 5, A–C and D–F, are summa-
rized in Fig. 6, A–C and D–F, respectively, and in Table 1.
The activation of Mo287Hu by caffeine and the suppression
of Mo230Hu are obvious (Fig. 6, A and C). Taken together,
these results show that the molecular determinant of
mTRPA1 activation by caffeine is situated in the N-terminal
cytoplasmic region between amino acid residues 231 and
287.Mo-Hu-Mo Hu-Mo-Hu100 µM)
A BEffect of swapping only the critical region
To further confirm the importance of the region between
amino acid residues 231 and 287, we constructed two
chimeras in which only this region is swapped: Mo-Hu-
Mo and Hu-Mo-Hu (Fig. 2). The currents recorded from5 mM Caffeine 100 µM AITC Caffeine after AITC
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FIGURE 6 Analysis of the cumulative data from the experiments in
Fig. 5. Details of the analyses are the same as in Fig. 4. Panels A–C and
D–F are from different batches of oocytes. Plots depict means 5 SE.
The data and n-values are shown in Table 1.oocytes expressing these two chimeras are shown in
Fig. 7, A and B, and the cumulative data are summarized
in Fig. 7, C–E, and Table 1. We found that Mo-Hu-Mo
was clearly inhibited by caffeine, especially after applica-
tion of AITC (Fig. 7, A–C, and E), which confirms that
without the region between amino acids 231 and 287,
mTRPA1 would not be activated by caffeine. By contrast,
Hu-Mo-Hu did not show a clear response to caffeine, or
even to AITC (Fig. 7, B and D). Thus, Hu-Mo-Hu provided
no information about the response to caffeine, which could
reflect the molecule’s lack of functionality or a lack of
surface expression. More complete overall integrity or unity
may be necessary for intact hTRPA1 expression and
function.10 mM
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FIGURE 7 Current recordings and analyses of Mo-Hu-Mo and Hu-Mo-
Hu. (A and B) Details of the experiments are the same as in Fig. 3, except
that 10 mM caffeine was used. (C–E) Details of the analyses are the same as
in Fig. 4, except that 10 mM caffeine was used. Plots depict means5 SE.
The data and n-values are shown in Table 1.
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FIGURE 8 Current recordings and analysis of
mTRPA1 point mutants. (A) Alignment of partial
amino acid sequences of mTRPA1 and hTRPA1.
The identified critical region is highlighted in black
(amino acids 231–287 of mTRPA1). Asterisks
indicate identical amino acid residues. (B) Repre-
sentative current recordings from oocytes express-
ing the indicated mTRPA1 point mutant. Under a
two-electrode clamp, 1.5-s ramp pulses from
100 to þ100 mV were applied twice from
a holding potential of 20 mV. The presence of
10 mM caffeine is indicated by the bar. (C) Ratios
of the current amplitudes at þ80 mV before and
after caffeine application. Plots depict means 5
SE. The data for Met268Pro were significantly
different from WT mTRPA1, but not from
hTRPA1. The data and n-values are shown in
Table 2.
3614 Nagatomo et al.A point mutation that changed the effect of
caffeine from activation to suppression
We next used point mutagenesis to identify the critical
amino acid residue that accounts for the difference in the
responses of mTRPA1 and hTRPA1 to caffeine. TakingBiophysical Journal 99(11) 3609–3618the result obtained with Mo-Hu-Mo into consideration
(Fig. 7), we decided to introduce human type mutations
on the background of mTRPA1. Amino acid residues 231–
287 are shown in black in Fig. 8 A, with asterisks indicating
the residues conserved between the murine and human
TABLE 2 Mean5 SE values of the ratio of the current amplitude at þ80 mV (mA) in the presence and absence of caffeine
Fig. 8 C mTRPA1 WT hTRPA1 WT T231L V236M H238N hTRPA1
Ratio 3.055 0.66 0.865 0.03 1.885 0.13 2.225 0.12 3.215 0.61
n-value 17 17 13 15 14
K239G S242T S250N D254E H265Q
Ratio 4.415 1.14 2.645 0.57 2.515 0.31 3.375 0.66 5.305 0.56
n-value 14 14 16 15 17
M268P M269V N271K/A272G M275T Non-inj
Ratio 0.855 0.03 5.965 0.59 4.185 0.34 4.305 0.29 0.985 0.02
n-value 14 13 13 13 17
Fig. 10 B hTRPA1 WT mTRPA1 WT P267M N237H/ P267M G238K/P267M
Ratio 0.775 0.04 6.075 0.66 0.655 0.02 0.645 0.02 0.705 0.05
n-value 11 11 12 13 11
N237H/G238K/P267M N239S/ P267M P267M/ V268M Non-inj
Ratio 0.695 0.03 0.765 0.01 0.785 0.02 0.935 0.02
n-value 12 12 11 9
Determinant of TRPA1 Caffeine Response 3615channels. We recorded from oocytes expressing the 11
single-point mutants and one double-point mutant shown
in Fig. 8 B, and the cumulative data are summarized in
Fig. 8 C and Table 2. One can see the effect of caffeine in
Fig. 8 B by comparing the currents elicited by ramp pulses
applied in the absence and presence of caffeine. Although
the extent of the activation varied, all of the mutants except
Met268Pro were clearly activated upon caffeine application.
Only with Met268Pro was the current amplitude suppressed
in a manner similar to that seen with hTRPA1 (Fig. 1 C).
Moreover, the caffeine dose-inhibition curve for Met268Pro
(Fig. 9) was very similar to that for hTRPA1 (Fig. 1 D).
We also confirmed that the response to AITC was retained
by Met268Pro (1.12 5 0.44 (mA), n ¼ 3; Fig. S3). These
results demonstrate that we were able to change the pheno-
type of mTRPA1 to that of hTRPA1 by substituting a Pro for
Met-268, which suggests that Met-268 in mTRPA1 (Pro-
267 in hTRPA1) may be the critical molecular determinant
for the species-specific difference in the caffeine response.
To further investigate the importance of Met-268, we also
substituted Met-268 of mTRPA1 with Cys, Ala, Trp, or Gly.
Cys has an -SH group instead of the -S-CH3 group in Met;
Ala andTrp are representative of small andbulky amino acids,
respectively; andGly has a structural flexibility that enables it
to kink in a manner similar to that of Pro. In contrast to
Met268Pro, however, therewas clear activation of the channel
by caffeine with all four of these mutants (Fig. 9, B–E).
Notably, reductions in the response amplitude at high caffeine
concentrations, which were not seen with WT mTRPA1
(Fig. 1 B), were clearly observed with the Cys, Ala, and Gly
mutants (Fig. 9, B, C, and E). This suggests that the Cys,
Ala, and Gly mutants may have dual features of activation
and activation-coupled desensitization, inactivation, or block,
and that their phenotypes may reflect aspects of both activa-
tion of mTRPA1 and suppression of hTRPA1. We also found
that rather bulky amino acid residues, such asMet or Trp, will
sustain caffeine-induced activation of mTRPA1, and that
introduction of Pro disrupts the activation phenotype of
mTRPA1,most likely by introducing a kink into the structure.It would be more appropriate to say that the absence of Pro at
268 of mTRPA1, rather than the presence of Met here, is crit-
ical for the activation effect of caffeine.
Finally, we analyzed the effect of introducing mouse
type point mutations on a background of hTRPA1 (Fig. 10).
The Pro267Met hTRPA1 mutant, which had the substitution
opposite to that of Met 268Pro, was not activated by caffeine
butwas clearly suppressed (Fig. 10,A andB). In addition, four
double-point mutants containing the Pro267Met substitution
plus an Asn237His, Gly238Lys, Asn249Ser, or Val268Met
substitution, and a triple mutant containing Pro267Met,
Asn237His, and Gly238Lys substitutions were also sup-
pressed, not activated, by caffeine (Fig. 10 B and Table 2).
These phenotypes were all similar to that of WT hTRPA1
(Fig. 1 B). It is thus plausible that the mechanism by which
caffeine activates mTRPA1 is more complex than the mecha-
nism by which it inhibits hTRPA1, and requires more struc-
tural background of mTRPA1 other than Met-268.DISCUSSION
Comparison of Met-268 with sites determining
the response of TRPA1 to other ligands
A number of amino acid residues involved in the response of
TRPA1 channels to various ligands have already been iden-
tified. It is now accepted that activation of TRPA1 channels
by reactive compounds such as AITC is due to covalent
modification of Cys residues (12,18). Furthermore, Hinman
et al. (18) identified Cys-621, Cys-641, and Cys-665, situ-
ated within the ankyrin repeat domain in the N-terminal
cytoplasmic region of hTRPA1, as critical factors in that
activation, and Macpherson et al. (12) identified Cys-415,
Cys-422, and Cys-622 in the same region of mTRPA1 as
being critical. It is unlikely, however, that the effect of
caffeine reflects such covalent modification, because
caffeine is not a reactive substance. We observed that the
Cys622Ser mutant, which reportedly does not respond to
AITC (12), was clearly activated by caffeine (Table S1 B).Biophysical Journal 99(11) 3609–3618
FIGURE 10 Current recordings and analyses of hTRPA1 point mutants.
(A) Details of the experiments are the same as in Fig. 8 B. (B) Details of the
analyses are the same as in Fig. 8 C. Plots depict means 5 SE. The data
obtained with the mutants did not statistically differ from WT hTRPA1.
The data and n-values are shown in Table 2.
FIGURE 9 Caffeine dose-response relationships of mTRPA1 Met-268
point mutants. The ratios of the current amplitudes at þ80 mV before
and after caffeine application are plotted against caffeine concentration.
Data for M268P (A), M268C (B), M268A (C), M268W (D), and M268G
(E) are shown. Open circles show data from each oocyte, and the solid dia-
monds and bars indicate means 5 SE. The n-values for each point range
from 1 to 4 (n ¼ 1 only for the case in which 0.1 mM was applied to
Met268Ala). The n-value of 0 mM caffeine is the sum of all other points,
since data before caffeine application were recorded as a negative control
in all experiments.
3616 Nagatomo et al.Zurborg et al. (19) reported that cytoplasmic Ca2þ directly
activates hTRPA1, and identified the negatively charged
Asp-468 and Asp-479 residues in the EF-hand motif in the
N-terminal cytoplasmic region as critical sites, and Doerner
et al. (20) reported that Leu-474 in the EF-hand motif is crit-
ical for Ca2þi sensitivity. On the other hand, in our study the
Ca2þi-insensitive mTRPA1 Asp469Ala and Leu475Ala
mutants did not show a qualitatively different response to
caffeine (Table S1, C and D), which confirms that the effect
of caffeine is not mediated by an increase in Ca2þi.
Tyrosine residues situated between TM1 and TM4 have
been identified as being critical for activation of TRPV1
by capsaicin or activation of TRPM8 by menthol (31,32).
Because all of these Tyr residues are conserved in mTRPA1
and hTRPA1, we were unable to analyze their function using
the chimera approach in this study. We therefore carried out
point mutation of Tyr residues in TM1–TM4 and found thatBiophysical Journal 99(11) 3609–3618none of these mutations, which included Tyr-728Ala (TM1),
Tyr-788Ala (TM2), Tyr-815Ala (TM3), Tyr-845Ala (TM4),
and Tyr-852Ala (TM4), affected the caffeine response of
mTRPA1 qualitatively (Table S1, E and F). We also intro-
duced a Tyr-1009Ala or Tyr-1009Leu mutation into the
cytoplasmic region, immediately after TM6, which
enhanced the responses to both AITC and caffeine
(Fig. S4 and Table S1 G), but this change likely reflects
an increase in the channel’s surface expression.
In this study, we carried out thorough and nonbiased
chimera analyses and identified the distal N-terminal cyto-
plasmic region of mTRPA1 between amino acid residues
231 and 287, which includes Met-268, as being critical for
the activation effect of caffeine. However, it remains to be
clarified whether Met-268 is the actual caffeine-binding
site or is the site of a critical conformational change that
occurs after caffeine binds to an adjacent region.Qualitative species-specific differences
in the ligand sensitivity of TRP channels
The qualitative species-specific differences in the ligand
sensitivity of some TRP channels and the structural back-
ground for that difference have been described previously.
One well-known example is TRPV1. Mammalian TRPV1
is activated by capsaicin, but the isoform from chick is
completely insensitive (31). With respect to TRPA1,
AMG5445, and AMG9090 are potent antagonists of
Determinant of TRPA1 Caffeine Response 3617hTRPA1 but are partial agonists of rTRPA1 (26). CMP1
activates rTRPA1 but blocks hTRPA1, and amino acid resi-
dues in the TM6 region, Ala-946 and Met-949 in rat, and
Ser-943 and Ile-946 in human are critical for that difference
(27). Menthol is known to have a bimodal action: it activates
mTRPA1 at low concentrations but inhibits the channel at
high concentrations (6). Xiao et al. (28) confirmed these
results and further showed that hTRPA1 is only activated
by menthol, even at high concentrations, and that
Drosophila TRPA1 is insensitive to methanol. Moreover,
they identified Ser-876 and Thr-877 in the TM5 region as
critical sites in determining the sensitivity to menthol (28).
The results summarized above suggest that species-
specific activation/suppression of TRPA1 is mainly switched
by residues in the TM5 and TM6 regions. These findings
might be expected because these TM regions form part of
the pore and gate of the channel. However, TM5 and TM6
do not appear to be involved in the species-specific difference
in the responses to caffeine, as replacements of the latter half
of the protein, including all of the TM regions, in Mo705Hu
and Hu703Mo (Fig. 3, C andD) did not change the channel’s
response to caffeine. Our results suggest the possibility that
the region between 231–287 amino acid residues within the
ankyrin repeat domain may serve not only as a simple on/
off switch, but also as a regulator of bifurcated responses to
caffeine.Possible mechanism for the bifurcated effects
of caffeine
It is clear that caffeine binds to both mTRPA1 and hTRPA1,
as both channels respond to the compound, though in oppo-
site ways. It is not yet clear whether Met-268 is the binding
site for caffeine, but given that the caffeine-induced confor-
mational change that couples with gating differs between
mouse and human, it seems reasonable to speculate that
the caffeine-binding site is in the three-dimensional prox-
imity of Met-268.
Upon substitution of Met-268 of mTRPA1 with Pro, as is
the case with hTRPA1, caffeine no longer activates the
channel, but suppresses it instead (Fig. 8). On the other
hand, the opposite substitution in hTRPA1 (Pro267Met)
and double-point mutations that included Pro267Met did
not confer the activation response to caffeine on hTRPA1
(Fig. 10), suggesting that additional mouse type mutations
are necessary to achieve activation. Similarly, Chen et al.
(27) were able to change the CMP1 response of rTRPA1
(activation) to an hTRPA1-like response (suppression), but
they also failed to confer the activation property on hTRPA1
using point mutagenesis.
A reduction in the amplitude of the activation responsewas
observed at higher caffeine concentrations with the mTRPA1
Met268Cys, Met268Ala, andMet268Gly mutants (Fig. 9 B).
This is reminiscent of the effect of menthol on mTRPA1
(6,28) and suggests that caffeine binding causes both activa-tion and a type of desensitization/inactivation that is coupled
to activation. Perhaps activation ofmTRPA1 and suppression
of hTRPA1 can be interpreted as parts of the same phenom-
enon, though with different aspects predominating.Another possible mechanism for the bifurcated
effects of caffeine
A second possibility is that the caffeine-induced suppression
of hTRPA1 currents reflects a sort of pore block. It is
possible that a sensitivity to caffeine block is shared by
both mTRPA1 and hTRPA1 but is masked in mTRPA1, as
caffeine also activates it. In the case of the Met268Pro
mutant, the blocking effect of caffeine is unmasked by the
disappearance of the activation effect. In this scenario, the
biphasic caffeine dose-response relationship seen with
M268C (Fig. 9 B), for example, might reflect a lower
EC50 for activation and higher IC50 for block.
If the current decrease of hTRPA1 by caffeine is due to
pore block, a mechanism that is totally unrelated to activa-
tion of mTRPA1, it is possible that the kinetics of the effect
differ between the two. We therefore analyzed their kinetics
(Fig. S5). The current decrease in hTRPA1 by 10 mM
caffeine could be fitted with two exponential functions,
and their time constants were 0.9 5 0.1 s and 7.0 5 0.7 s
(n ¼ 10; Fig. S5, A, B, and E). The activation phase of
mTRPA1 could be also fitted with two exponential
functions with time constants of 1.6 5 0.3 s and 17.0 5
3.3 s (n ¼ 10; Fig. S5, C–E). Because the values were in
a similar order range, the results did not positively support
the notion that the decrease is due to a totally different
mechanism, such as pore block. However, the data do not
exclude the possibility that the decrease is due to pore block,
since the speed of pore block could be rather slow depend-
ing on the rate.
To further examine the possibility that the current
decrease is due to pore block, we made chimera constructs
based on the caffeine-insensitive rat TRPV1, whose latter
half after TM5 was replaced with that of hTRPA1 or
mTRPA1. We also made similar chimera constructs based
on the caffeine-insensitive rat TRPM8. We expected that
the chimeras might show a current decrease upon caffeine
application if the decrease was due to block at the pore
region. However, none of the chimeras were functional
and they showed no response to their ligands (data not
shown). Therefore, the mechanism for the current decrease
of hTRPA1 by caffeine, including the possibility of pore
block, remains to be determined.Physiological significance of species-specific
differences in the caffeine response
Met-268 is conserved in mice and rats, whereas Pro-267 is
conserved in humans, chimpanzees, and monkeys. The
sequence in the region containing Met-268 not wellBiophysical Journal 99(11) 3609–3618
3618 Nagatomo et al.conserved in zebrafish, Drosophila, or mosquitos, which
have Gln, Thr, and Thr, respectively, at the corresponding
site. It is possible that mice acquired the capability to sense
caffeine as a pungent substance to avoid its intake, and that
the Met-to-Pro mutation occurred in monkeys to allow
intake of caffeine so that they could take advantage of its
useful pharmacological effects.SUPPORTING MATERIAL
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